Lutz Stefan, Chief Scientific Officer at Codexis, Inc. ($CDXS), made three open market sales of company shares over the last year, totaling $17,848. His most recent sale occurred on February 24, 2026. These transactions rank 11,088th out of 11,678 individual insiders in our database by sale value, well below the average of $8.6 million across 6.37 transactions per insider. Stefan recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | CODEXIS, INC. | $CDXS | Lutz Stefan | Chief Scientific Officer | S | Common Stock | 5862 | $1.13 | 130,421.0000 | 90,324,383 | 4.30% | 0.01% |
| Feb. 23, 2026 | CODEXIS, INC. | $CDXS | Lutz Stefan | Chief Scientific Officer | A | Stock Option (Right to Buy) | 316100 | $0.00 | 316,100.0000 | 90,324,383 | 9999.99% | 0.35% |
| Feb. 6, 2026 | CODEXIS, INC. | $CDXS | Lutz Stefan | Chief Scientific Officer | S | Common Stock | 2492 | $1.31 | 136,283.0000 | 90,324,383 | 1.80% | 0.00% |
| Jan. 7, 2026 | CODEXIS, INC. | $CDXS | Lutz Stefan | CSO | S | Common Stock | 4685 | $1.70 | 138,775.0000 | 90,324,383 | 3.27% | 0.01% |